XM tillhandahåller inte tjänster till personer bosatta i USA.
W
W

Wacker


Nyheter

Wacker Chemie's stock rises, analysts point to U.S new duties on solar imports from Southeast Asia

BUZZ-Wacker Chemie's stock rises, analysts point to U.S new duties on solar imports from Southeast Asia ** Wacker Chemie's WCHG.DE stock rises 3.4%, as analysts point to US Commerce Department's anti subsidy countervailing duties on solar cell and panel imports from four southeast Asian countries as a reason for the rise ** "I think the share price rise is due to the announcement of anti subsidy countervailing duties on solar cell and panel imports from four southeast Asian countries by the US C
W

Europe's chemicals rise boosted by Chinese stimulus

BUZZ-Europe's chemicals rise boosted by Chinese stimulus ** European benchmark chemicals index .SX4P is up 2.2%, with German firms leading gains boosted by Chinese stimulus measures announced earlier this week ** BASF BASFn.DE , K+S SDFGn.DE and Wacker Chemie WCHG.DE all rise 5-7% ** Sebastian Bray, analyst at Berenberg, says BASF's shares are also
B
K
W

Burberry, Hermes, Spectris

EUROPE RESEARCH ROUNDUP-Burberry, Hermes, Spectris Sept 20 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Burberry, Hermes and Spectris on Friday. HIGHLIGHTS * ASML Holding NV ASML.AS : Morgan Stanley cuts to equal-weight from overweight * Burberry BRBY.L : Jefferies cuts to underperform from hold * Hermes HRMS.PA : Jefferies cuts target price to EUR 2,200 from EUR 2,470 * Intercontinental Hotels IHG.L : HSBC cuts target price to 7
A
A
A
B
B
C
C
D
E
E
F
F
G
H
J
K
L
O
R
S
S
W
A
S

Wacker Chemie Confirms Strategy And Long-Term Growth Targets

BRIEF-Wacker Chemie Confirms Strategy And Long-Term Growth Targets Sept 19 (Reuters) - WACKER CHEMIE AG WCHG.DE : WACKER CHEMIE AG - CONFIRMS STRATEGY AND LONG-TERM GROWTH TARGETS WACKER CHEMIE AG - SALES TO REACH 10 BILLION BY 2030; EBITDA MARGIN OF OVER 20 PERCENT TARGETED Source text for Eikon: ID:nPex1H6gTa Further company coverage: WCHG.DE (Gd
W

Wacker Chemie Says Minervax And Wacker Biotech To Collaborate On Prophylactic Vaccine

BRIEF-Wacker Chemie Says Minervax And Wacker Biotech To Collaborate On Prophylactic Vaccine Sept 17 (Reuters) - WACKER CHEMIE AG WCHG.DE : MINERVAX AND WACKER BIOTECH ANNOUNCE MANUFACTURING COLLABORATION FOR PROPHYLACTIC VACCINE TARGETING GROUP B STREPTOCOCCUS MINERVAX SCALING UP SUPPLY OF NOVEL GBS VACCINE, AHEAD OF PHASE III STUDIES WACKER BIOTEC
W

MS says 2025 turning point for EU chemicals, names Akzo as top pick

BUZZ-MS says 2025 turning point for EU chemicals, names Akzo as top pick ** Current demand growth in European chemicals lacks near term catalysts, but is set to improve from 2025, supported by interest rates' cuts and lower gas prices, says Morgan Stanley ** MS analysts anticipate 2.7% supply growth on average over the next four years (vs 4.6% over
A
B
L
W
A
A

Top of the Street: Wacker Chemie, Air Liquide, RS Group

BUZZ-Top of the Street: Wacker Chemie, Air Liquide, RS Group A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Morgan Stanley raises Wacker Chemie WCHG.DE to "overweight" from "equal-weight" saying the German chemical company's earnings quality is improving thanks to its shift towards more stable, premium products in polysilicon and silicones ** MS cuts French industrial gases supplier Air Liquide AIRP.PA to "underweight" from "equal-weight" seeing a cycli
W
A

Air Liquide, Novo Nordisk, Syensqo

EUROPE RESEARCH ROUNDUP- Air Liquide, Novo Nordisk, Syensqo Sept 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air Liquide, Novo Nordisk and Syensqo, on Thursday. HIGHLIGHTS * Air Liquide AIRP.PA : Morgan Stanley cuts to underweight from equal-weight * Lanxess AG LXSG.DE : Morgan Stanley raises to overweight from underweight * Novo Nordisk NOVOb.CO : JP Morgan raises target price to DKK 1050 from DKK 950 * Swiss Life Holding AG
A
A
A
A
B
B
C
E
K
L
N
W
A
A
A
S
S

Clariant cuts sales target on weak catalyst business, shares fall

UPDATE 2-Clariant cuts sales target on weak catalyst business, shares fall Writes through to add sales outlook, details on catalysts business, share reaction and analyst comment By Chiara Holzhaeuser and Antonis Pothitos July 30 (Reuters) - Shares in Clariant CLN.S fell 7.5% on Tuesday after the Swiss speciality chemicals maker lowered its full-year sales forecast due to a weak performance in its catalysts unit, overshadowing a hike in its margin target.
C
W

Wacker Chemie sees 2024 core profit in upper guidance range as orders pick up

UPDATE 2-Wacker Chemie sees 2024 core profit in upper guidance range as orders pick up Sees 2024 EBITDA between 700 mln and 800 mln euros Lower Q2 total sales dragged by weaker polysilicon business Q2 EBITDA above analyst estimates of 160.1 mln euros Adds CEO quote, analyst quote, share movement, details on polysilicon division, peer performance By Antonis Pothitos and Matteo Allievi July 26 (Reuters) - German chemical company Wacker Chemie WCHG.DE expects full-year core profit in the upper half
B
W

Wacker Chemie's Q2 core profit beats expectations as orders pick up

Wacker Chemie's Q2 core profit beats expectations as orders pick up July 26 (Reuters) - German chemical company Wacker Chemie WCHG.DE on Friday reported a second-quarter core profit above analyst estimates, as demand stabilised and orders picked up. The specialty chemicals maker posted earnings before interest, taxes, depreciation and amortisation (EBITDA) of 160.1 million euros ($173.82 million), beating the 156.7 million euros expected by analysts in a company-provided poll , but 37% down from
W

Wacker Chemie Expects 2024 EBITDA In Upper Half Of Projected Range

BRIEF-Wacker Chemie Expects 2024 EBITDA In Upper Half Of Projected Range July 26 (Reuters) - WACKER CHEMIE AG WCHG.DE : Q2 NET CASH FLOW COMES IN AT EUR -179 MILLION FULL-YEAR FORECAST CONFIRMED CEO - WE NOW EXPECT THAT EBITDA WILL BE IN UPPER HALF OF PROJECTED RANGE Source text for Eikon: ID:nPexlfVcLa Further company coverage: WCHG.DE (Gdansk New
W



Villkor

Populära tillgångar

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.